IsoTis OrthoBiologics Reports Third Quarter Results
Published: Nov 09, 2006
LAUSANNE, Switzerland and IRVINE, CA, Nov. 9 /CNW/ - IsoTis S.A. (SWX/Euronext: ISON) (TSX: ISO), the orthobiologics company, today reported its results for the third quarter and nine months ended September 30, 2006. Revenues were $10.2 million for the third quarter of 2006, representing a 25% increase over revenues of $8.1 million for the third quarter of 2005. For the first nine months of 2006, revenues were $30.8 million, representing a 31% increase over revenues of $23.5 million for the same period in 2005.